As of Mar 7, 2025, the CRGX stock has a P/E ratio of 0.05. The calculation is based on the latest EPS of $78.85 and the stock price of $3.96 per share.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | N/A | N/A | $23.15 | -$16.53 |
2022 | N/A | N/A | N/A | -$104.4 |
2021 | N/A | N/A | N/A | -$2.83 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 0.23 | -54.9% | $18.45 | $78.85 |
Jun 2024 | 0.51 | -84.4% | $16.42 | $32.36 |
Mar 2024 | 3.27 | N/A | $22.32 | $6.82 |
Dec 2023 | N/A | N/A | $23.15 | -$16.53 |
Sep 2023 | N/A | N/A | N/A | -$120.53 |
Jun 2023 | N/A | N/A | N/A | -$101.54 |
Mar 2023 | N/A | N/A | N/A | N/A |
Dec 2022 | N/A | N/A | N/A | -$104.4 |
Sep 2022 | N/A | N/A | N/A | N/A |
Dec 2021 | N/A | N/A | N/A | -$2.83 |
When compared to its peer stocks AMGN and GILD, CRGX's PE ratio is lower. CARGO Therapeutics is currently trading at a lower PE ratio (0.05) than its peers average of 28.76.
Stock name | PE ratio | Market cap |
---|---|---|
CRGX CARGO Therapeutics Inc | 0.05 | $182.27M |
BIIB Biogen Inc | 13.41 | $22.01B |
REGN Regeneron Pharmaceuticals Inc | 17.3 | $77.35B |
SRPT Sarepta Therapeutics Inc | 41.71 | $10B |
AMGN Amgen Inc | 42.63 | $174.52B |
GILD Gilead Sciences Inc | 308.97 | $146.22B |
VRTX Vertex Pharmaceuticals Inc | N/A | $125.39B |
ALNY Alnylam Pharmaceuticals Inc | N/A | $31.65B |
MRNA Moderna Inc | N/A | $13.74B |
NVAX Novavax Inc | N/A | $1.34B |
As of Mar 7, 2025, CRGX stock has a price to earnings ratio of 0.05.
CRGX's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Mar 7, 2025), CARGO Therapeutics's share price is $3.96. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $78.85. Therefore, CARGO Therapeutics's price to earnings ratio for today is 0.05. PE RATIO(0.05) = STOCK PRICE($3.96) / TTM EPS($78.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.